{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:36:03Z","timestamp":1790728563737,"version":"4.1.0"},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Tobacco smoking is the leading cause of disability and preventable deaths worldwide, but it should be differentiated from tobacco use disorder, which is, according to the Diagnostic and Statistical Manual of Mental Disorders, a <jats:italic>bona fide<\/jats:italic> mental disorder. The rapid delivery of nicotine to the brain activates acetylcholine receptors and stimulates the release of dopamine, both systems implicated in other mental disorders. Rates of tobacco use disorder are much higher among people suffering from other mental disorders and these patients find it more difficult to quit. Dual disorders, from a transdiagnostic perspective, identify patients with substance use disorder, in this case tobacco use disorder, and other mental disorders. A dual disorder is a complex clinical condition that is often underdiagnosed, undertreated, and difficult to manage. Appropriate and integrated tobacco use disorder treatment programs for people also suffering from other mental disorders could improve outcomes. Bio-psycho-social approaches to tobacco use disorder include specific biological treatments (e.g., bupropion, varenicline, cytisine, nicotine replacement therapy or deep trans-magnetic stimulation). However, these treatments don\u2019t have the same outcomes in patients with dual disorders. Therefore, as in other dual disorders, harm reduction measures, such as vaping nicotine through electronic cigarettes or tobacco replacement therapies should be considered as alternative tools for dual tobacco use disorder management. These clinical considerations emerge from a narrative literature review and expert consensus and will specifically address considerations for changes in clinical practice to improve the treatment of tobacco use disorder and other mental disorders.<\/jats:p>","DOI":"10.3389\/fpsyt.2024.1427561","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T04:38:00Z","timestamp":1728621480000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Tobacco use disorder in patients with other mental disorders: a dual disorder perspective from clinical neuroscience"],"prefix":"10.3389","volume":"15","author":[{"given":"Nestor","family":"Szerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Parro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Basurte-Villamor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Ruiz-Veguilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5334\/aogh.2417","article-title":"Tobacco use worldwide: legislative efforts to curb consumption","volume":"85","author":"Perez-Warnisher","year":"2019","journal-title":"Ann Glob Health"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/add.15309","article-title":"Tobacco use disorder and the lungs","volume":"116","author":"McRobbie","year":"2021","journal-title":"Addiction"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjpmh.2024.04.002","article-title":"Tobacco use disorder and other mental disorders: The neglected dual disorder","author":"Parro-Torres","year":"2024","journal-title":"Span J Psychiatry Ment Health"},{"key":"B4","first-page":"77","article-title":"Tobacco use disorder (TUD) and dual disorders: joint statement by the spanish psychiatry society and the spanish dual disorders society","volume":"50","author":"Szerman","year":"2022","journal-title":"Actas Esp Psiquiatr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/10550490590924728","article-title":"Co-morbidity of smoking in patients with psychiatric and substance use disorders","volume":"14","author":"Kalman","year":"2005","journal-title":"Am J Addict"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031816-044618","article-title":"Smoking, mental illness, and public health","volume":"38","author":"Prochaska","year":"2017","journal-title":"Annu Rev Public Health"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1037\/pha0000585","article-title":"Contingency management for smokers with mental health disorders and smoking-sensitive conditions caused or exacerbated by tobacco use: A review of existing studies, intervention parameters, and research priorities","volume":"31","author":"Gonzalez-Roz","year":"2023","journal-title":"Exp Clin Psychopharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jaac.2018.06.029","article-title":"Mental health problems and onset of tobacco use among 12- to 24-year-olds in the PATH study","volume":"57","author":"Green","year":"2018","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B9","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.neubiorev.2021.11.039","article-title":"The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis","volume":"132","author":"Fornaro","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2012.00263.x","article-title":"Mental disorders and cigarette use among adults in the United States","volume":"21","author":"Goodwin","year":"2012","journal-title":"Am J Addict"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9758\/cpn.2015.13.1.1","article-title":"Tobacco use in bipolar disorder","volume":"13","author":"Thomson","year":"2015","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/146642400512500213","article-title":"Anxiety, depression and smoking in schoolchildren\u2013implications for smoking prevention","volume":"125","author":"Dudas","year":"2005","journal-title":"J R Soc Promot Health"},{"key":"B13","first-page":"A42","article-title":"Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states","volume":"3","author":"Colton","year":"2006","journal-title":"Prev Chronic Dis"},{"key":"B14","article-title":"Dual disorders: two different mental disorders","volume":"8","author":"Szerman","year":"2015","journal-title":"Adv Dual Diagnosis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41398-022-02212-5","article-title":"World Association on Dual, Addictive and other mental disorders: a call for a standardized definition of dual disorders","volume":"12","author":"Szerman","year":"2022","journal-title":"Transl Psychiatry"},{"key":"B16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12888-021-03188-0","article-title":"Scope, quality and inclusivity of international clinical guidelines on mental health and substance abuse in relation to dual diagnosis, social and community outcomes: a systematic review","volume":"21","author":"Alsuhaibani","year":"2021","journal-title":"BMC Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2013.00304.x","article-title":"Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC)","volume":"22","author":"Lev-Ran","year":"2013","journal-title":"Am J Addict"},{"key":"B18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S2215-0366(18)30424-3","article-title":"Outcome of Psychosis, Smoking, symptoms, and quality of life in patients with psychosis, siblings, and healthy controls: a prospective, longitudinal cohort study","volume":"6","author":"Vermeulen","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"B19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0006-3223(03)00317-2","article-title":"Psychiatric disorders and stages of smoking","volume":"55","author":"Breslau","year":"2004","journal-title":"Biol Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntaa197","article-title":"Discrimination, sexual orientation discrimination, and severity of tobacco use disorder in the United States: results from the national epidemiologic survey on alcohol and related conditions-III","volume":"23","author":"Kcomt","year":"2021","journal-title":"Nicotine Tob Res"},{"key":"B21","first-page":"298","article-title":"Factors associated with tobacco consumption in patients with depression","volume":"31","author":"Jimenez-Trevino","year":"2019","journal-title":"Adicciones"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.284985","article-title":"Trends in smoking among adults with mental illness and association between mental health treatment and smoking cessation","volume":"311","author":"Cook","year":"2014","journal-title":"JAMA"},{"key":"B23","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/jcpp.12855","article-title":"Substance use through adolescence into early adulthood after childhood-diagnosed ADHD: findings from the MTA longitudinal study","volume":"59","author":"Molina","year":"2018","journal-title":"J Child Psychol Psychiatry"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1037\/a0036585","article-title":"The role of early childhood ADHD and subsequent CD in the initiation and escalation of adolescent cigarette, alcohol, and marijuana use","volume":"123","author":"Sibley","year":"2014","journal-title":"J Abnorm Psychol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/14622200110050457","article-title":"The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-being","volume":"3","author":"Degenhardt","year":"2001","journal-title":"Nicotine Tob Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1176\/appi.ps.24075011","article-title":"The imperative to treat tobacco use disorder","volume":"75","author":"Kager","year":"2024","journal-title":"Psychiatr Serv"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.8.1181","article-title":"Drug abuse and mental illness: progress in understanding comorbidity","volume":"158","author":"Volkow","year":"2001","journal-title":"Am J Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20796","article-title":"Managing dual disorders: a statement by the Informal Scientific Network, UN Commission on Narcotic Drugs","volume":"19","author":"Volkow","year":"2020","journal-title":"World Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.3390\/jcm9082406","article-title":"Concurrent disorder management guidelines","volume":"9","author":"Hakobyan","year":"2020","journal-title":"Systematic Review. J Clin Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200207020-00006","article-title":"Effect of nicotine and nicotinic receptors on anxiety and depression","volume":"13","author":"Picciotto","year":"2002","journal-title":"Neuroreport"},{"key":"B31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pnpbp.2013.07.010","article-title":"Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems","volume":"52","author":"Mackowick","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e24306","DOI":"10.7759\/cureus.24306","article-title":"Impact of nicotine on cognition in patients with schizophrenia: A narrative review","volume":"14","author":"Spasova","year":"2022","journal-title":"Cureus"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.804055","article-title":"Evidence for schizophrenia-specific pathophysiology of nicotine dependence","volume":"13","author":"Ward","year":"2022","journal-title":"Front Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2018.1512727","article-title":"Precision psychiatry and dual disorders","volume":"14","author":"Szerman","year":"2018","journal-title":"J Dual Diagn"},{"key":"B35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrn1883","article-title":"The therapeutic potential of monoamine oxidase inhibitors","volume":"7","author":"Youdim","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12666","article-title":"Toward precision medicine in addiction treatment","volume":"27","author":"Volkow","year":"2018","journal-title":"Am J Addict"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2019.05.014","article-title":"Increasing depression and substance use among former smokers in the United States, 2002-2016","volume":"57","author":"Cheslack-Postava","year":"2019","journal-title":"Am J Prev Med"},{"key":"B38","doi-asserted-by":"crossref","first-page":"110723","DOI":"10.1016\/j.pnpbp.2023.110723","article-title":"Nicotine\u2019s effect on cognition, a friend or foe","volume":"124","author":"Wang","year":"2023","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s44220-023-00034-y","article-title":"Multivariate genome-wide association meta-analysis of over 1 million subjects identifies loci underlying multiple substance use disorders","volume":"1","author":"Hatoum","year":"2023","journal-title":"Nat Ment Health"},{"key":"B40","doi-asserted-by":"publisher","first-page":"106716","DOI":"10.1016\/j.phrs.2023.106716","article-title":"Nicotine on the developing brain","volume":"190","author":"Castro","year":"2023","journal-title":"Pharmacol Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"107ra109","DOI":"10.1126\/scitranslmed.3003062","article-title":"Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine","volume":"3","author":"Levine","year":"2011","journal-title":"Sci Transl Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jaac.2013.04.003","article-title":"Striatum-based circuitry of adolescent depression and anhedonia","volume":"52","author":"Gabbay","year":"2013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay9763","article-title":"Current advances in research in treatment and recovery: Nicotine addiction","volume":"5","author":"Prochaska","year":"2019","journal-title":"Sci Adv"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/add.12353","article-title":"Pharmacotherapy effects on smoking cessation vary with nicotine metabolism gene (CYP2A6)","volume":"109","author":"Chen","year":"2014","journal-title":"Addiction"},{"key":"B45","first-page":"15248380221122818","article-title":"Association between adverse childhood experiences and a combination of psychosis and violence among adults: A systematic review and meta-analysis","volume":"24","author":"Ranu","year":"2022","journal-title":"Trauma Violence Abuse"},{"key":"B46","doi-asserted-by":"publisher","first-page":"106091","DOI":"10.1016\/j.chiabu.2023.106091","article-title":"Type and dose-response effect of adverse childhood experiences in predicting depression: A systematic review and meta-analysis","volume":"139","author":"Tan","year":"2023","journal-title":"Child Abuse Negl"},{"key":"B47","volume-title":"Adolescent brain cognitive development (ABCD) study","year":"2024"},{"key":"B48","volume-title":"HEALthy brain and child development (HBCD) study","year":"2024"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1101\/cshperspect.a012120","article-title":"Short- and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function","volume":"2","author":"Goriounova","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1384408","article-title":"Chronic tobacco smoking and neurocognitive impairments in adolescents and young adults: a systematic review and meta-analysis","volume":"15","author":"Elatfy","year":"2024","journal-title":"Front Psychiatry"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e2225991","DOI":"10.1001\/jamanetworkopen.2022.25991","article-title":"Longitudinal assessments of neurocognitive performance and brain structure associated with initiation of tobacco use in children, 2016 to 2021","volume":"5","author":"Dai","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2017.08.009","article-title":"Co-occurrence of tobacco product use, substance use, and mental health problems among youth: Findings from wave 1 (2013-2014) of the population assessment of tobacco and health (PATH) study","volume":"76","author":"Conway","year":"2018","journal-title":"Addict Behav"},{"key":"B53","doi-asserted-by":"publisher","first-page":"106764","DOI":"10.1016\/j.phrs.2023.106764","article-title":"Nicotinic acetylcholine receptors in neurological and psychiatric diseases","volume":"191","author":"Terry","year":"2023","journal-title":"Pharmacol Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4684","DOI":"10.1038\/s41467-023-40079-2","article-title":"Association between vmPFC gray matter volume and smoking initiation in adolescents","volume":"14","author":"Xiang","year":"2023","journal-title":"Nat Commun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1209277","article-title":"Early-onset smoking theory of compulsivity development: a neurocognitive model for the development of compulsive tobacco smoking","volume":"14","author":"Conti","year":"2023","journal-title":"Front Psychiatry"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2023.02.008","article-title":"Prevalence of tobacco smoking in people at clinical high-risk for psychosis: Systematic review and meta-analysis","volume":"254","author":"De Micheli","year":"2023","journal-title":"Schizophr Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1814130","article-title":"Adolescent vaping and nicotine use in 2017-2018 - U","volume":"380","author":"Miech","year":"2019","journal-title":"S. Natl Estimates. N Engl J Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/08897077.2019.1580241","article-title":"Understanding the implications of the \u201cvaping epidemic\u201d among adolescents and young adults: A call for action","volume":"40","author":"Chadi","year":"2019","journal-title":"Subst Abus"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6839a2","article-title":"Flavored tobacco product use among middle and high school students - United States, 2014-2018. MMWR","volume":"68","author":"Cullen","year":"2019","journal-title":"Morb Mortal Wkly Rep"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2012.08.036","article-title":"Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior","volume":"76","author":"Picciotto","year":"2012","journal-title":"Neuron"},{"key":"B61","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.pharmtox.48.113006.094742","article-title":"Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics","volume":"49","author":"Benowitz","year":"2009","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2018.1458090","article-title":"Discovery and development of varenicline for smoking cessation","volume":"13","author":"Jordan","year":"2018","journal-title":"Expert Opin Drug Discovery"},{"key":"B63","doi-asserted-by":"publisher","first-page":"CD003999","DOI":"10.1002\/14651858.CD003999.pub4","article-title":"Relapse prevention interventions for smoking cessation","author":"Hajek","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B64","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s12888-017-1419-7","article-title":"Smoking cessation in severe mental ill health: what works? an updated systematic review and meta-analysis","volume":"17","author":"Peckham","year":"2017","journal-title":"BMC Psychiatry"},{"key":"B65","doi-asserted-by":"publisher","first-page":"CD000146","DOI":"10.1002\/14651858.CD000146.pub5","article-title":"Nicotine replacement therapy versus control for smoking cessation","volume":"5","author":"Hartmann-Boyce","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B66","doi-asserted-by":"publisher","first-page":"CD009329","DOI":"10.1002\/14651858.CD009329.pub2","article-title":"Pharmacological interventions for smoking cessation: an overview and network meta-analysis","volume":"2013","author":"Cahill","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B67","first-page":"27","article-title":"Smokers with serious mental illness and requests for nicotine replacement therapy post-hospitalisation","volume":"25","author":"Schuck","year":"2016","journal-title":"Tob Control"},{"key":"B68","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/B978-0-12-420118-7.00005-6","article-title":"Bupropion and bupropion analogs as treatments for CNS disorders","volume":"69","author":"Carroll","year":"2014","journal-title":"Adv Pharmacol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/add.13415","article-title":"Varenicline for smoking cessation and reduction in people with severe mental illnesses: systematic review and meta-analysis","volume":"111","author":"Wu","year":"2016","journal-title":"Addiction"},{"key":"B70","doi-asserted-by":"publisher","first-page":"E596","DOI":"10.1503\/cmaj.171371","article-title":"Cytisine for smoking cessation","volume":"190","author":"Karnieg","year":"2018","journal-title":"CMAJ"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.10042","article-title":"Cytisinicline for smoking cessation: A randomized clinical trial","volume":"330","author":"Rigotti","year":"2023","journal-title":"JAMA"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30272-0","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial","volume":"387","author":"Anthenelli","year":"2016","journal-title":"Lancet"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001015","article-title":"Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with psychotic, anxiety, and mood disorders in the EAGLES trial","volume":"39","author":"Evins","year":"2019","journal-title":"J Clin Psychopharmacol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/add.13236","article-title":"Efficacy and tolerability of pharmacotherapy for smoking cessation in adults with serious mental illness: a systematic review and network meta-analysis","volume":"111","author":"Roberts","year":"2016","journal-title":"Addiction"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2016.11.018","article-title":"Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder","volume":"183","author":"Evins","year":"2017","journal-title":"Schizophr Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143490","article-title":"Varenicline effects on smoking, cognition, and psychiatric symptoms in schizophrenia: A double-blind randomized trial","volume":"11","author":"Smith","year":"2016","journal-title":"PloS One"},{"key":"B77","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.drugalcdep.2017.06.020","article-title":"ADHD symptoms impact smoking outcomes and withdrawal in response to Varenicline treatment for smoking cessation","volume":"179","author":"Bidwell","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/nty033","article-title":"Effects of varenicline, depressive symptoms, and region of enrollment on smoking cessation in depressed smokers","volume":"21","author":"Doran","year":"2019","journal-title":"Nicotine Tob Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-020-05451-w","article-title":"The effect of varenicline on mood and cognition in smokers with HIV","volume":"237","author":"Thompson","year":"2020","journal-title":"Psychopharmacol (Berl)"},{"key":"B80","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/wps.20905","article-title":"Repetitive transcranial magnetic stimulation for smoking cessation: a pivotal multicenter double-blind randomized controlled trial","volume":"20","author":"Zangen","year":"2021","journal-title":"World Psychiatry"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.969500","article-title":"Insula deep rTMS and varenicline for smoking cessation: A randomized control trial study protocol","volume":"13","author":"Ibrahim","year":"2022","journal-title":"Front Pharmacol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.1079138","article-title":"Moderators of the response to deep TMS for smoking addiction","volume":"13","author":"Gersner","year":"2022","journal-title":"Front Psychiatry"},{"key":"B83","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am J Drug Alcohol Abuse"},{"key":"B84","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neulet.2018.01.022","article-title":"Sub-anesthetic doses of ketamine attenuate nicotine self-administration in rats","volume":"668","author":"Rezvani","year":"2018","journal-title":"Neurosci Lett"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntv245","article-title":"Contribution of monoamine oxidase inhibition to tobacco dependence: A review of the evidence","volume":"18","author":"Hogg","year":"2016","journal-title":"Nicotine Tob Res"},{"key":"B86","article-title":"New tobacco product regulations in the era of reduced harm. Should Europe follow the FDA\u2019s example","volume":"19","author":"Richter","year":"2021","journal-title":"e-J Cardiol Pract"},{"key":"B87","doi-asserted-by":"crossref","DOI":"10.1080\/17425247.2019.1665647","article-title":"What is the nicotine delivery profile of electronic cigarettes","volume":"16","author":"Voos","year":"2019","journal-title":"Expert Opin Drug Delivery"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0215-2021","article-title":"E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials","volume":"31","author":"Hanewinkel","year":"2022","journal-title":"Eur Respir Rev"},{"key":"B89","first-page":"CD010216","article-title":"Electronic cigarettes for smoking cessation","volume":"1","author":"Lindson","year":"2024","journal-title":"Cochrane Database Systematic Rev"},{"key":"B90","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/tobaccocontrol-2017-053759","article-title":"Potential deaths averted in USA by replacing cigarettes with e-cigarettes","volume":"27","author":"Levy","year":"2018","journal-title":"Tob Control"},{"key":"B91","doi-asserted-by":"publisher","first-page":"13825","DOI":"10.1038\/s41598-017-14043-2","article-title":"Health impact of E-cigarettes: a prospective 3.5-year study of regular daily users who have never smoked","volume":"7","author":"Polosa","year":"2017","journal-title":"Sci Rep"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1808779","article-title":"A randomized trial of E-cigarettes versus nicotine-replacement therapy","volume":"380","author":"Hajek","year":"2019","journal-title":"N Engl J Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2024.1822","article-title":"Electronic cigarettes vs varenicline for smoking cessation in adults: A randomized clinical trial","volume":"184","author":"Tuisku","year":"2024","journal-title":"JAMA Intern Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntac029","article-title":"Biomarkers of exposure and biomarkers of potential harm in adult smokers who switch to e-vapor products relative to cigarette smoking in a 24-week, randomized, clinical trial","volume":"24","author":"Edmiston","year":"2022","journal-title":"Nicotine Tob Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.21246","article-title":"Secondhand nicotine absorption from E-cigarette vapor vs tobacco smoke in children","volume":"7","author":"Tattan-Birch","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph10020446","article-title":"Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study","volume":"10","author":"Caponnetto","year":"2013","journal-title":"Int J Environ Res Public Health"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291718001782","article-title":"A pre-post pilot study of electronic cigarettes to reduce smoking in people with severe mental illness","volume":"49","author":"Hickling","year":"2019","journal-title":"Psychol Med"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-023-08137-z","article-title":"Electronic cigarettes: an overlooked tool to alleviate disparities in tobacco use disorder among people with mental health and substance use disorders","volume":"38","author":"Vuong","year":"2023","journal-title":"J Gen Intern Med"},{"key":"B99","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.yrtph.2010.12.002","article-title":"Summary of the epidemiological evidence relating snus to health","volume":"59","author":"Lee","year":"2011","journal-title":"Regul Toxicol Pharmacol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.2196\/42628","article-title":"Comparing the effectiveness, tolerability, and acceptability of heated tobacco products and refillable electronic cigarettes for cigarette substitution (CEASEFIRE): randomized controlled trial","volume":"9","author":"Caponnetto","year":"2023","journal-title":"JMIR Public Health Surveill"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntz084","article-title":"Favorable changes in biomarkers of potential harm to reduce the adverse health effects of smoking in smokers switching to the menthol tobacco heating system 2.2 for 3 months (Part 2)","volume":"22","author":"Haziza","year":"2020","journal-title":"Nicotine Tob Res"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-18-0915","article-title":"Effects of switching to a heat-not-burn tobacco product on biologically relevant biomarkers to assess a candidate modified risk tobacco product: A randomized trial","volume":"28","author":"Ludicke","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntw287","article-title":"Effects of switching to the tobacco heating system 2.2 menthol, smoking abstinence, or continued cigarette smoking on biomarkers of exposure: A randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (Part 1)","volume":"20","author":"Ludicke","year":"2018","journal-title":"Nicotine Tob Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntx028","article-title":"Effects of switching to the menthol tobacco heating system 2.2, smoking abstinence, or continued cigarette smoking on clinically relevant risk markers: A randomized, controlled, open-label, multicenter study in sequential confinement and ambulatory settings (Part 2)","volume":"20","author":"Ludicke","year":"2018","journal-title":"Nicotine Tob Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18126651","article-title":"Exposure to heated tobacco products and adverse health effects, a systematic review","volume":"18","author":"Znyk","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B106","first-page":"40","article-title":"Evidencia cienti\u0301fica sobre productos de tabaco calentado. Una revisio\u0301n narrativa","volume":"46","author":"Gonzalez-Moro","year":"2021","journal-title":"Rev Esp Drogodep"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2016.03.009","article-title":"Appeal of electronic cigarettes in smokers with serious mental illness","volume":"59","author":"Pratt","year":"2016","journal-title":"Addict Behav"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.72.6.1144","article-title":"A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery","volume":"72","author":"Prochaska","year":"2004","journal-title":"J Consult Clin Psychol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"g1151","DOI":"10.1136\/bmj.g1151","article-title":"Change in mental health after smoking cessation: systematic review and meta-analysis","volume":"348","author":"Taylor","year":"2014","journal-title":"BMJ 348"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291703008869","article-title":"Daily smoking and the subsequent onset of psychiatric disorders","volume":"34","author":"Breslau","year":"2004","journal-title":"Psychol Med"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(19)30047-1","article-title":"Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial","volume":"6","author":"Gilbody","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"B112","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-022-00346-w","article-title":"Tobacco and nicotine use","volume":"8","author":"Le Foll","year":"2022","journal-title":"Nat Rev Dis Primers"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1427561\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T04:38:05Z","timestamp":1728621485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2024.1427561\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":112,"alternative-id":["10.3389\/fpsyt.2024.1427561"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2024.1427561","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,11]]},"article-number":"1427561"}}